XML 64 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating activities:    
Net income (loss) $ 32,521 $ (75,610)
Adjustments to reconcile net income (loss) to net cash provided from operating activities:    
Loss from equity method investments, net of distributions 2,732 610
Deferred income tax expense (benefit) 18,951 (47,205)
Depletion, depreciation and amortization 128,682 115,101
Exploration dry hole costs 1 (159)
Abandonment and impairment of unproved properties 9,995 15,218
Derivative fair value loss 146,850 99,875
Cash settlements on derivative financial instruments that do not qualify for hedge accounting (104,584) 382
Amortization of deferred financing costs and other 2,873 2,080
Deferred and stock-based compensation 12,593 54,991
Loss on the sale of assets 353 166
Changes in working capital:    
Accounts receivable (41,643) 1,292
Inventory and other (5,358) 166
Accounts payable 9,997 17,061
Accrued liabilities and other (32,742) 17,281
Net cash provided from operating activities 181,221 201,249
Investing activities:    
Additions to natural gas and oil properties (226,331) (259,601)
Additions to field service assets (3,084) (1,071)
Acreage purchases (50,690) (8,794)
Equity method investments 2,511 1,885
Proceeds from disposal of assets 294 38,196
Purchases of marketable securities held by the deferred compensation plan (8,247) (17,936)
Proceeds from the sales of marketable securities held by the deferred compensation plan 9,310 6,316
Net cash used in investing activities (276,237) (241,005)
Financing activities:    
Borrowing on credit facilities 412,000 368,000
Repayment on credit facilities (318,000) (1,060,000)
Issuance of subordinated notes   750,000
Dividends paid (6,550) (6,521)
Debt issuance costs   (12,098)
Issuance of common stock   343
Change in cash overdrafts (1,122) (12,458)
Proceeds from the sales of common stock held by the deferred compensation plan 8,586 12,432
Net cash provided from financing activities 94,914 39,698
Decrease in cash and cash equivalents (102) (58)
Cash and cash equivalents at beginning of period 348 252
Cash and cash equivalents at end of period $ 246 $ 194